|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2022):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational new drugs, Bd. 40: S. 163-171
[PDF, 1MB]
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171
Gennen, Kathrin; Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Karin, Monika; Roengvoraphoj, Olarn; Neumann, Jens; Tufman, Amanda; Orth, Michael; Reu, Simone; Belka, Claus und Manapov, Farkhad
(2020):
Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
In: Radiation Oncology, Bd. 15, Nr. 1, 5
Taugner, Julian; Eze, Chukwuka; Kaesmann, Lukas; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2020):
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
In: Radiation Oncology, Bd. 15, Nr. 1, 148
Hoffmann, Michael; Reitz, Daniel; Taugner, Julian; Roengvoraphoj, Olarn; Kaesmann, Lukas; Eze, Chukwuka; Karin, Monika; Belka, Claus und Manapov, Farkhad
(2020):
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy.
In: Anticancer Research, Bd. 40, Nr. 4: S. 2319-2322
Karin, Monika; Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2020):
Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis.
In: Cancers, Bd. 12, Nr. 10, 3035
Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petruknov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.
In: Translational Lung Cancer Research, Bd. 8, Nr. 5: S. 593-604
Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
In: Anticancer Research, Bd. 39, Nr. 9: S. 5077-5081